LILLY-I1F-MC-RHBL

Study Sponsor: Lilly

Study Title

Pharmacokinetic Evaluations of Ixekizumab Following Subcutaneous Administration Using Prefilled Syringe or Auto-Injector in Patients With Moderate-to-Severe Plaque Psoriasis UNCOVER-A

Medicine or Vaccine (generic name)

Ixekizumab

Sponsor Identification Number

I1F-MC-RHBL

Trial Registry Identification Number(#'s)

NCT01777191

Medical Condition

Psoriasis

Phase

Phase 3

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01777191?term=I1F-MC-RHBL&rank=1

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

November 2016